Hironori Fujii, Masami Tsuchiya, Daichi Watanabe, Ryo Otsuka, Daisuke Hirate, Katsuyuki Takahashi, Makiko Go, Toshihiro Kudo, Kazuhiro Shimomura, Yosuke Ando, et al. The emerging emetogenicity of trifluridine/tipiracil (TAS-102) from patient self-reporting: a multicenter, prospective, observational study. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2024. 32. 5. 291-291
Daichi Watanabe, Hironori Fujii, Koichi Ohata, Hirotoshi Iihara, Akitaka Makiyama, Ryo Kobayashi, Chiemi Hirose, Shiori Hishida, Serika Matsuoka, Jesse Yu Tajima, et al. Prognostic impact of severe neutropenia in colorectal cancer patients treated with TAS-102 and bevacizumab, addressing immortal-time bias. BMC cancer. 2023. 23. 1. 1078-1078
Hironori Fujii, Yunami Yamada, Hirotoshi Iihara, Akio Suzuki. The role of pharmacists in multimodal cancer cachexia care. Asia-Pacific journal of oncology nursing. 2023. 10. Suppl 1. 100280-100280
Seiji Yamamoto, Hironori Fujii, Kotaro Murayama, Hirotoshi Iihara, Daichi Watanabe, Yunami Yamada, Ryo Kobayashi, Shigeru Kiyama, Akitaka Makiyama, Kimihiko Urano, et al. Efficacy and Safety of Oxaliplatin-based Regimens as First-line Chemotherapy in Elderly Patients With Metastatic Colorectal Cancer. Anticancer research. 2023. 43. 11. 5099-5105
Association between capecitabine efficacy and proton pump inhibitors in patients with stage II-III colorectal cancer: A retrospective multicenter study
(ESMO congress 2021 2021)
がん化学療法において薬剤師が持つべき Creativity
(第77回 医療薬学公開シンポジウム in 岐阜 2021)